We devised a strategy to test this using an siRNA screening approach in two different human soft-tissue sarcoma cell lines: RD cells which have wild-type Rho GTPases and HT-1080 cells which contain an oncogenic N92I RAC1 mutation [23]. This evidence concerns the gene RAC1 and soft tissue sarcoma.